Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism
Cited in blog · Science Translational Medicine. · 2024
Zhou, Y., et al. (2024). *Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism*. Science Translational Medicine.
Authors
Zhou, Y., et al.
Research lens
Zhou, Y., et al. (2024). *Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism*. Science Translational Medicine.
- blog
- psilocybin-chemo-nerve-damage-2026-10-02